Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Newecka

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Medical and Pediatric Oncology|September 24, 1999
Childhood stage IV Hodgkin disease: therapeutic results of the Polish pediatric leukemia/lymphoma study groupJ Armata, W Balwierz, A Moryl-Bujakowska, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|March 25, 2000
[Does residual mediastinal mass in children with completed treatment of Hodgkin's disease affect the incidence of relapses?]W Balwierz, J Armata, A Moryl-Bujakowska, et al.
Medycyna Wieku Rozwojowego|May 11, 2002
[Treatment regimen for children and adolescents with Hodgkin's disease designed to decrease late complications of radiotherapy]W Balwierz, A Moryl-Bujakowska, T Depowska, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Medical and Pediatric Oncology|September 24, 1999
Childhood stage IV Hodgkin disease: therapeutic results of the Polish pediatric leukemia/lymphoma study groupJ Armata, W Balwierz, A Moryl-Bujakowska, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|March 25, 2000
[Does residual mediastinal mass in children with completed treatment of Hodgkin's disease affect the incidence of relapses?]W Balwierz, J Armata, A Moryl-Bujakowska, et al.
Medycyna Wieku Rozwojowego|May 11, 2002
[Treatment regimen for children and adolescents with Hodgkin's disease designed to decrease late complications of radiotherapy]W Balwierz, A Moryl-Bujakowska, T Depowska, et al.
Pageof 3